IQBAL J HUSSAIN
CIK 1862050 · Chief Legal Officer · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
49
Lifetime Open-Market Net
-$4.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Legal Officer | 0 | $40.50 | $0 | -$4.15M | 34 | 2026-06-24 |
Recent Filings · Page 4 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-17 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | −71,705 | -$1.24M | EDGAR |
| 2024-12-16 | — | Notice (144) | −77,705 | -$1.29M | EDGAR |
| 2024-10-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −7,520 | -$118.7K | EDGAR |
| 2024-07-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −7,520 | -$67.9K | EDGAR |
| 2024-04-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −7,520 | -$85.0K | EDGAR |
| 2024-02-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | +34,615 | -$64.6K | EDGAR |
| 2024-01-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −7,520 | -$59.9K | EDGAR |
| 2023-10-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −7,520 | -$48.7K | EDGAR |
| 2023-07-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −7,104 | -$41.9K | EDGAR |
| 2023-04-04 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −7,080 | -$27.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.